STAAR Surgical Co Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- STAAR Surgical Co stock issued during period, value, stock options exercised for the quarter ending 2026-07-03 was $1.24M, a 11127.27% increase year-over-year.
- STAAR Surgical Co stock issued during period, value, stock options exercised for the quarter ending 2026-04-03 was $170.00K, a 54.79% decline year-over-year.
- STAAR Surgical Co stock issued during period, value, stock options exercised for the quarter ending 2026-01-02 was $114.00K, a 185.00% increase year-over-year.
- STAAR Surgical Co stock issued during period, value, stock options exercised for the quarter ending 2025-09-26 was $2.96M, a 78.88% increase year-over-year.
- STAAR Surgical Co stock issued during period, value, stock options exercised for fiscal 2026 was $3.46M, a 53.13% decline from fiscal 2024.
- STAAR Surgical Co stock issued during period, value, stock options exercised for fiscal 2024 was $7.39M, a 23.57% decline from fiscal 2023.
- STAAR Surgical Co stock issued during period, value, stock options exercised for fiscal 2023 was $9.67M, a 14.84% increase from fiscal 2022.
- STAAR Surgical Co stock issued during period, value, stock options exercised for fiscal 2022 was $8.42M, a 56.67% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-07-03 | $1.24M 10-Q · filed 2026-08-12 | $4.48M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-04-03 | $170.00K 10-Q · filed 2026-05-13 | $3.26M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-01-02 | $114.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $3.46M 10-K · filed 2026-03-03 |
| 2025-09-26 | $2.96M 10-Q · filed 2025-11-05 | $3.39M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-27 | $11.00K 10-Q · filed 2026-08-12 | $2.08M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-28 | $376.00K 10-Q · filed 2026-05-13 | $2.44M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-27 | $40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $7.39M 10-K · filed 2026-03-03 |
| 2024-09-27 | $1.66M 10-Q · filed 2025-11-05 | $7.76M derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-06-28 | $371.00K 10-Q · filed 2025-08-06 | $13.36M derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-03-29 | $5.32M 10-Q · filed 2025-05-07 | $14.47M derived: sum of 4 quarters · filed 2026-03-03 |
| 2023-12-29 | $408.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $9.67M 10-K · filed 2026-03-03 |
| 2023-09-29 | $7.26M 10-Q · filed 2024-10-30 | $9.51M derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-06-30 | $1.48M 10-Q · filed 2024-08-07 | $7.28M derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-03-31 | $529.00K 10-Q · filed 2024-05-07 | $8.04M derived: sum of 4 quarters · filed 2025-02-21 |
| 2022-12-30 | $243.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $8.42M 10-K · filed 2025-02-21 |
| 2022-09-30 | $5.03M 10-Q · filed 2023-11-06 | $9.29M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-07-01 | $2.23M 10-Q · filed 2023-08-02 | $8.47M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-04-01 | $912.00K 10-Q · filed 2023-05-03 | $14.12M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $19.44M 10-K · filed 2024-02-27 |
| 2021-10-01 | $4.21M 10-Q · filed 2022-11-02 | $24.98M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-07-02 | $7.88M 10-Q · filed 2022-08-10 | $25.20M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-04-02 | $6.23M 10-Q · filed 2022-05-04 | $24.88M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-01-01 | $6.66M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $20.65M 10-K · filed 2023-02-23 |
| 2020-10-02 | $4.43M 10-Q · filed 2021-11-03 | $15.62M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-07-03 | $7.55M 10-Q · filed 2021-08-04 | $11.91M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-04-03 | $2.00M 10-Q · filed 2021-05-05 | $4.84M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-01-03 | $1.63M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $3.46M 10-K · filed 2022-02-23 |
| 2019-09-27 | $719.00K 10-Q · filed 2020-11-04 | $2.44M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-28 | $487.00K 10-Q · filed 2020-08-05 | $3.90M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-29 | $623.00K 10-Q · filed 2020-05-06 | $5.37M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-28 | $615.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $5.20M 10-K · filed 2021-02-24 |
| 2018-09-28 | $2.17M 10-Q · filed 2019-10-30 | |
| 2018-06-29 | $1.95M 10-Q · filed 2019-07-31 | |
| 2018-03-30 | $453.00K 10-Q · filed 2019-05-01 | |
| 2017-12-29 | $3.97M 10-K · filed 2020-02-26 | |
| 2016-12-30 | $2.44M 10-K · filed 2019-02-21 | |
| 2016-01-01 | $2.17M 10-K · filed 2018-02-28 | |
| 2015-01-02 | $3.02M 10-K · filed 2017-03-02 | |
| 2014-01-03 | $3.29M 10-K · filed 2016-03-11 | |
| 2012-12-28 | $1.51M 10-K · filed 2015-03-13 | |
| 2011-12-30 | $3.34M 10-K · filed 2014-03-12 | |
| 2010-12-31 | $1.12M 10-K · filed 2012-03-08 | |
| 2010-01-01 | $1.00K 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |